At a glance
ClinicalIndex Comparison RecordN/ACompleted· 61 enrolled
Drug / intervention
LYNX Mobile Appbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing and Pre-exposure Prophylaxis (PrEP) for Young Men Who Have Sex With Men
In Brief
A clinical study evaluating LYNX Mobile App for HIV and 3 related conditions. Completed, enrolled 61 participants across 2 sites.
Detailed Summary
This study is testing the acceptability and feasibility of a highly interactive mobile application (app) to promote HIV/sexually transmitted infection (STI) testing and uptake of pre-exposure prophylaxis (PrEP) among young men who have sex with men (YMSM).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsCook County Health & Hospitals System, Duke University, Emory University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), San Francisco Department of Public Health, University of California, San Francisco, University of North Carolina, Chapel Hill, University of South Florida
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2017
Enrollment StartOct 2018
Primary CompletionNov 2019
TodayJul 2026
First PostedJun 6, 2017
Enrollment StartOct 25, 2018
Primary CompletionNov 18, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.1 years ago
Interventions
LYNX Mobile Appbehavioral
Access to the LYNX mobile app which includes the Sex Pro score tool, PrEP videos, HIV/STI testing reminders and geo-location features.